✦ LIBER ✦

Etoposide resistance in MCF-7 breast cancer cell line is marked by multiple mechanisms

✍ Scribed by Alpsoy, Aktan; Yasa, Seda; Gündüz, Ufuk

Book ID: 121681571
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 614 KB
Volume: 68
Category: Article
ISSN: 0753-3322
DOI: 10.1016/j.biopha.2013.09.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene expression alterations in doxorubic

Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line

✍ AbuHammad, Shatha; Zihlif, Malek 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 917 KB

Is the MCF-7 breast cancer cell line of

Is the MCF-7 breast cancer cell line of value in research?

✍ H. Bahia; J. Ashman; L. Cawkwell; V. Hordison; A. Abidia; M. Lind; P. Drew; J. G 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 129 KB

128 Genetic Expression Alterations in Do

128 Genetic Expression Alterations in Doxorubicin Resistant MCF7 Breast Cancer Cell-Line

✍ Zihlif, M.; AbuHammad, S.M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Reversal of Multidrug Resistance by Nefe

Reversal of Multidrug Resistance by Neferine in Adriamycin Resistant Human Breast Cancer Cell Line MCF-7/ADM

✍ Jianguo Cao; Hong Zhou; Bo Peng; Xiaoqing Tang 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 174 KB

Mechanisms of acquired resistance to ins

Mechanisms of acquired resistance to insulin-like growth factor 1 receptor inhibitor in MCF-7 breast cancer cell line

✍ Roudy Chiminch Ekyalongo,Toru Mukohara,Yu Kataoka… 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 622 KB

Annamycin circumvents resistance mediate

Annamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposide

✍ Roman Perez-Soler; Nouri Neamati; Yiyu Zou; Erasmus Schneider; L. Austin Doyle; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 144 KB 👁 2 views

Annamycin (Ann) is a highly lipophilic anthracycline antibiotic that has been shown to circumvent MDR-1 both in vitro and in vivo. A liposomal formulation of Ann is currently in phase I clinical trials. The multidrug resistance-associated protein (MRP) has been found to be over-expressed in some hum